Cosmetic Surgery Market Forecasts to 2028 – Global Analysis By Procedure Type (Non-invasive Procedures and Invasive procedures), Gender (Female and Male), Age Group (13-29, 30-54 and 55 and above), End User and Geography

Cosmetic Surgery Market Forecasts to 2028 – Global Analysis By Procedure Type (Non-invasive Procedures and Invasive procedures), Gender (Female and Male), Age Group (13-29, 30-54 and 55 and above), End User and Geography

According to Stratistics MRC, the Global Cosmetic Surgery Market is accounted for $56.85 billion in 2022 and is expected to reach $79.29 billion by 2028 growing at a CAGR of 5.7% during the forecast period. Cosmetic surgery is a voluntary operation that patients undergo in order to modify their bodies, contour their bodies, and improve their physical appearance. Cosmetic surgery is a distinct branch of medicine that focuses on improving appearance through surgical and medicinal treatments. Cosmetic surgery can be performed on any part of the head, neck, or body. Cosmetic surgery is optional because treated parts function normally but lack aesthetic appeal. Cosmetic surgery encompasses a wide range of procedures.

According to the data published by the International Society of Aesthetic Plastic Surgery (ISAPS) in 2020, it was reported that around 225,177 liposuction, 905,958 botulinum toxin, and 298,070 hair removal were among the most common procedures performed on men.

Market Dynamics:

Driver:

Rising focus on aesthetic features

As beauty has become a significant component of daily life, the demand for cosmetic operations has gradually changed in recent years. The increase in population focusing on aesthetic characteristics has created potential business prospects. Women's preference for aesthetic procedures such as breast augmentation, liposuction, eyelid surgery, abdominoplasty, and others is driving up market demand for cosmetic procedures. People prefer non-surgical therapies for a variety of reasons, including shorter recovery times, less pain, and lower healthcare expenses. The factors listed above, as well as increased R&D investments and new product launches by key players, are driving and contributing to market expansion.

Restraint:

Complications associated with cosmetic procedure

A variety of issues may arise during or after the cosmetic surgery. Non-physician operations performed in salons, spas, and other non-medical environments are producing an increasing number of issues. Scars, swelling, infections, and nerve damage are some of the most common consequences of cosmetic operations. Furthermore, the adverse effects of utilising face fillers are a major barrier limiting market expansion. Redness, skin pigmentation, bruising, crooked smile, inflammatory reaction, and other problems are prevalent. People have safety concerns, which reduces the number of people who have cosmetic operations. This aspect has played a significant role in lowering the demand for cosmetic surgeries.

Opportunity:

Increasing demand for cosmetic procedures among male population

Because of age-related concerns, the popularity and adoption of cosmetic treatments among the male population is increasing year after year, and men are choosing these procedures to keep their youthful appearance. Furthermore, rising demand for nonsurgical procedures such as dermal fillers and botulinum toxin procedures among men is driving up the number of procedures performed and contributing to total market development. The aforementioned variables, as well as the steadily better gender balance, are increasing the total demand for cosmetic operations among the male population.

Threat:

Presence of an unregulated market

Various countries have seen an increase in the number of illegal sellers offering cosmetic operations and luring a sizable section of the population eager to undergo aesthetic procedures. These facilities, such as unlicensed medical practitioners and surgeons, have a negative impact on the market. This aspect contributes to an increase in the number of cosmetic procedures that go wrong, with patients accepting substandard materials and implants. Increasing incidences of undesirable effects of aesthetic surgery associated to an uncontrolled market are expected to restrain the growth of the cosmetic surgery market during the projected period.

Covid-19 Impact

The COVID-19 epidemic is expected to have a detrimental impact on the growth of the worldwide cosmetic surgery market. A number of clinics and hospitals were restructured in order to boost hospital capacity for COVID-19 patients. The implementation of lockdown due to the COVID-19 epidemic resulted in a decrease in the frequency of patient visits for aesthetic operations during the pandemic. Cosmetic surgical operations are non-emergency procedures that have considerably affected the profitability of aesthetic companies. Interest in non-invasive procedures has increased during the past few months while interest in invasive procedures has declined.

The non-invasive procedures segment is expected to be the largest during the forecast period

The non-invasive procedures segment is estimated to have a lucrative growth, due to the growing popularity and higher patient population undergoing non-invasive procedures such as dermal filler, botulinum toxin, hyaluronic acid, and others. This increased popularity can be attributed to the several advantages provided, such as shorter recovery times, lower hospitalisation rates, painless treatments, and more. Botox injections, soft tissue fillers, chemical peels, and other non-invasive procedures are popular.

The hospitals & clinic segment is expected to have the highest CAGR during the forecast period

The Hospitals & Clinic segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increase in number of cosmetic surgeries, and rise in number of hospitals and clinics to conduct various surgical procedures. In comparison to other facilities, hospitals and clinics execute the majority of cosmetic treatments. Furthermore, the increased demand for minimally invasive procedures, as well as patients’ preference for clinics, is driving category expansion.

Region with highest share:

North America is projected to hold the largest market share during the forecast period owing to the presence of highly qualified plastic surgeons performing various cosmetic procedures and the growing number of aesthetic clinics in the U.S. and Canada. Furthermore, sophisticated healthcare infrastructure, cosmetic treatment acceptance, rising prevalence of skin problems, and the existence of board-certified and professional cosmetic surgeons in the region are some of the primary factors driving market expansion.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period. The growing popularity of noninvasive procedures, as well as the opening of new medical spas in countries such as Germany and France, is driving market expansion in this region. The availability of technologically sophisticated items, as well as the increased emphasis on physical attractiveness, is expected to drive the regional market.

Key players in the market

Some of the key players profiled in the Cosmetic Surgery Market include Syneron Candela, Solta Medical, AbbVie, Lumenis, Cynosure, Evolus, Inc., Galderma S.A., Bausch Health Companies Inc., Alma Lasers, MerzPharma GmbH & Co. KGaA, Johnson and Johnson, Apyx Medical

Key Developments:

In July 2022, Cutera announced the approval for AviClear, the first and only laser treatment device approved in the U.S. to cure mild, moderate, and severe acne.

In June 2022, Cynosure launched the PicoSure Pro Device, which has an advanced lens focus array made of Platinum which would help to reduce wrinkles, acne scars and pores by increasing the content of collagen and elastin.

In February 2021, Merz Pharma announced the launch of BELOTERO BALANCE + Lidocaine in the U.S. The BELOTERO BALANCE is a hyaluronic acid (HA) filler for etchedin lines & advantages of lidocaine formulation provides a perfect finish to filler patients.

In July 2020, Bausch Health Companies Inc.’s Solta Medical has released the radiofrequency device-Thermage FLX system, designed to tighten skin. Thermage FLX is the only FDA-approved system for the treatment of eyelids.

Procedure Types Covered:
• Non-invasive Procedures
• Invasive procedures

Genders Covered:
• Female
• Male

Age Groups Covered:
• 13-29
• 30-54
• 55 and above

End Users Covered:
• Hospital and Clinic
• Office and Cosmetic Surgical Center
• Ambulatory Surgical Facility

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements